UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
IBO holding history
Impact Biomedical Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBO overviewAll 13F holders of IBOFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,400
- Value
- $1.10K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,400 | $1.10K | <0.1% | −30,017−92.6% | Reduced | Holders |
| Q1 2026 | 32,417 | $19.4K | <0.1% | +30,248+1,394.6% | Added | Holders |
| Q4 2025 | 2,169 | $1.09K | <0.1% | −17,919−89.2% | Reduced | Holders |
| Q3 2025 | 20,088 | $13.4K | <0.1% | −19,637−49.4% | Reduced | Holders |
| Q2 2025 | 39,725 | $25.7K | <0.1% | +23,558+145.7% | Added | Holders |
| Q1 2025 | 16,167 | $14.1K | <0.1% | +11,915+280.2% | Added | Holders |
| Q4 2024 | 4,252 | $6.17K | <0.1% | +4,249+141,633.3% | Added | Holders |
| Q3 2024 | 3 | $6 | <0.1% | +3 | New | Holders |